canine adenovirus 10 IU, canine distemper virus 10 IU, canine parvovirus 10 IU, Leptosira Canicola, Leptosira Icterohaemorrhagiae 1 IU, leptospira interrogans serogroup canicola 1 IU - search results

France - English - HMA (Heads of Medicines Agencies)

duramune dap + l

fort dodge animal health - canine adenovirus 10 iu, canine distemper virus 10 iu, canine parvovirus 10 iu, leptosira canicola, leptosira icterohaemorrhagiae 1 iu, leptospira interrogans serogroup canicola 1 iu - suspension for injection - dogs - live canine distemper virus vaccine + live canine adenovirus vaccine + live canine parvovirus vaccine + inactivated leptospira v

Austria - English - HMA (Heads of Medicines Agencies)

duramune dap+l

Greece - English - HMA (Heads of Medicines Agencies)

duramune dap+l

Spain - English - HMA (Heads of Medicines Agencies)

duramune dap+l

Italy - English - HMA (Heads of Medicines Agencies)

duramune dap+l

United Kingdom - English - HMA (Heads of Medicines Agencies)

duramune dap+l

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

duramune adult c4 canine distemper, adenovirus, parainfluenza & parvovirus live vaccine

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parainfluenza type 2; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parainfluenza type 2 vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

duramune adult c3 canine distemper, adenovirus & parvovirus live vaccine

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parvovirus | parvovirus

European Union - English - EMA (European Medicines Agency)

versican plus dhppi/l4r

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

Philippines - English - FDA (Food And Drug Administration)

megavac-6 formulation: each 1 ml (dose) contains: canine distemper virus ........>10^3 tcid50 canine adenovirus type 2 .............................. > 10^3 tcid50 canine parvovirus .................................. >128 ha canine adenovirus type 1 ................ > 81 sn50/ 0.05 ml leptospira interrogans ser. canicola leptospira interrogans ser. icterohaemorrhagiae tcid - tissue culture infective dose ha - hemagglutination assay sn-serum neutralization freeze-dried pellet for injection (im/sc)

unahco, inc.; distributor: unahco, inc. - live canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , inactivated canine adenovirus type 1 (cav-1) , leptospira interrogans ser. canicola , l. interrogans ser. ictero haemorrhagiae vaccine (vet.) - freeze-dried pellet for injection (im/sc) - formulation: each 1 ml (dose) contains: canine distemper virus ........>10^3 tcid50 canine adenovirus type 2 .............................. > 10^3 tcid50 canine parvovirus .................................. >128 ha canine adenovirus type 1 ................ > 81 sn50/ 0.05 ml leptospira interrogans ser. canicola leptospira interrogans ser. icterohaemorrhagiae tcid - tissue culture infective dose ha - hemagglutination assay sn-serum neutralization